Jean-Charles Soria to Neoplasm Proteins
This is a "connection" page, showing publications Jean-Charles Soria has written about Neoplasm Proteins.
Connection Strength
0.062
-
A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours. Eur J Cancer. 2018 11; 104:1-8.
Score: 0.031
-
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade. J Clin Invest. 2018 04 02; 128(4):1671-1687.
Score: 0.030